Women's Health

The women’s health channel includes news, videos, podcasts and other content related to technology used to detect and treat breast cancer and cervical cancer, including mammography, breast magnetic resonance imaging (MRI), automated breast ultrasound (ABUS), breast ultrasound, breast biopsy and breast radiation therapy.

The study published as the front-page cover paper of the January issue of IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.​​​​​​​ Image courtesy of POSTECH
News | Point-of-Care Ultrasound (POCUS)
Combining Two Different Ultrasounds for Accurate Breast Cancer Detection

February 4, 2022 — A new diagnostic tool for breast cancer that combines two ultrasounds has been developed. A POSTECH ...

Time February 04, 2022
arrow
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced today the details of its first national, direct-to-consumer advertising campaign. The campaign will launch with a 30-second spot on NBC during the “Big Game” on February 13, 2022, and run through the Winter Olympics across NBCU television and digital channels.
News | Women's Health
Hologic Launches First-ever National Advertising Campaign Featuring Mary J. Blige

February 3, 2022 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...

Time February 03, 2022
arrow
49-Year-Old Woman Presenting for Screening Mammography, Revealing Right Breast Architectural Distortion: (A) Right craniocaudal, (B) mediolateral oblique, (C) spot compression tomosynthesis images show architectural distortion in right breast at 12 o’clock position (arrows). No sonographic correlate identified. Tomosynthesis-guided needle biopsy yielded radial scar—not upgraded at surgery.
News | Breast Imaging
Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology

February 3, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), imaging surveillance is a ...

Time February 03, 2022
arrow
Urgent and immediate action must be taken to ensure more effective and equitable implementation of cancer screening, according to a report released today by the President's Cancer Panel.
News | Radiology Imaging
President's Cancer Panel Calls for Urgent Action to Address Gaps in Cancer Screening Uptake

February 2, 2022 — Urgent and immediate action must be taken to ensure more effective and equitable implementation of ...

Time February 02, 2022
arrow
Before TIL therapy, a woman with breast cancer had metastatic lesions in her chest wall (top, left) and liver (bottom, left). After receiving the immunotherapy, her tumors shrank completely, and recent scans (right) show that she remains cancer free more than five years later.National Cancer Institute
News | Breast Imaging
NIH Study Advances Personalized Immunotherapy for Metastatic Breast Cancer

February 1, 2022 — An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could ...

Time February 01, 2022
arrow
The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period.
News | Breast Imaging
Insights on the Mammography Devices Global Market to 2026

January 31, 2022 — The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at ...

Time January 31, 2022
arrow
The world market for breast imaging equipment is forecast to reach almost $1.3 billion by 2024, and the breast imaging artificial intelligence (AI) market is forecast to reach $205 million, according to a new report from Signify Research.
Feature | Breast Imaging | By Bhvita Jani
Global Drivers of the Breast Imaging Market

The rising global incidence rates of breast cancer, coupled with the severe backlog of women requiring breast cancer ...

Time January 20, 2022
arrow
Today, as part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the health of all women, the Center for Devices and Radiological Health (CDRH) is sharing its Health of Women Program Strategic Plan. CDRH initially issued a proposed strategic plan in September 2019 and has considered public feedback to inform this strategic plan, which lays out the framework to further the FDA’s mission by protecting and promoting the health of women, strengthening regulatory science, and
News | Women's Health
FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation

January 18, 2022 — The following statement was issued today by the U.S. Food and Drug Administration (FDA), and is ...

Time January 18, 2022
arrow
UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market.
News | Breast Imaging
UE LifeSciences and Siemens Healthineers Launch iBreastExam in the U.S.

January 18, 2022 — UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers ...

Time January 18, 2022
arrow
57-Year-Old Woman Presented for Screening Mammography: Digital, A, and tomosynthesis, B, craniocaudal images showed 1.8 cm asymmetry (arrows) lateral left breast categorized as BI-RADS 0. C, Ultrasound left breast evaluation revealed normal fibroglandular tissue (arrow) believed to correlate with mammographic finding. D, Asymmetry effaced on rolled lateral craniocaudal imaging. Metallic BB marker noted at 12 o’clock position, anterior depth. Final assessment BI-RADS 1. Image courtesy of ARRS
News | Ultrasound Women's Health
Recalled Noncalcified Lesions: Ultrasound vs. Ultrasound Plus Mammography

January 17, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), radiologists should ...

Time January 17, 2022
arrow
Most AI for spotting pre-cancerous lesions in mammography scans don’t reveal any of their decision-making process (top). If they do, it’s often a saliency map (middle) that only tells doctors where they’re looking. A new AI platform (bottom) not only tells doctors where it’s looking, but which past experiences its using to draw its conclusions.
News | Mammography
The First AI Breast Cancer Sleuth That Shows Its Work

January 14, 2022 — Computer engineers and radiologists at Duke University have developed an artificial intelligence ...

Time January 14, 2022
arrow
Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base.
News | Mammography
Infinitt announces Partnership with Lunit

January 13, 2022 — Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare ...

Time January 13, 2022
arrow
Less-experienced radiologists are more likely to recommend additional imaging for women undergoing breast cancer screening when they read digital breast tomosynthesis (DBT) images later in the day, according to a new study in Radiology.
News | Breast Imaging
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs

January 11, 2022 — Less-experienced radiologists are more likely to recommend additional imaging for women undergoing ...

Time January 11, 2022
arrow
Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak report on industry leaders in diagnostic imaging equipment in the United States.
News | Radiation Oncology
Varian and Siemens Healthineers Recognized in Survey of U.S. Radiation Oncology and Diagnostic Imaging Professionals

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

Time January 07, 2022
arrow
The AI software is integrated into Gestalt Diagnostics's PathFlow platform for streamlined access and workflow for BioReference's pathologists and external pathology customers. This makes BreastIHC the first AI-based product in pathology to be used in routine clinical practice in the United States.
News | Digital Pathology
Gestalt Diagnostics and MindPeak Provide the First Artificial Intelligence Based Diagnostics Solution Used in Clinical Routine Pathology in the USA

January 5, 2022 — Hamburg, Germany, based Mindpeak and Spokane, Wash., based Gestalt Diagnostics have achieved a major ...

Time January 05, 2022
arrow
Videos | Breast Imaging
VIDEO: Mammography Trends and Advances at RSNA 2021

Stamatia Destounis, M.D., FACR, chief of the American College of Radiology (ACR) Breast Commission, managing partner ...

Time December 13, 2021
arrow
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of ProFound AI for Digital Breast Tomosynthesis (DBT) was highlighted at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 – December 2.
News | Breast Imaging
iCAD Announced Compelling New and Real-World Data Demonstrating the Value of ProFound AI at RSNA21

December 10, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time December 10, 2021
arrow
A Michigan Tech-developed machine learning model uses probability to more accurately classify breast cancer shown in histopathology images and evaluate the uncertainty of its predictions.
News | Breast Imaging
Machine Learning Reduces Uncertainty in Breast Cancer Diagnoses

December 8, 2021 — A Michigan Tech-developed machine learning model uses probability to more accurately classify breast ...

Time December 08, 2021
arrow
Figure 1. Left image shows breast MRI in 41-year-old patient without IUD. Right image shows increased parenchymal enhancement in the same patient 27 months after IUD placement.
Feature | Radiology Imaging | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in November 2021

December 8, 2021 — Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of November ...

Time December 08, 2021
arrow
IceCure Medical Ltd., developer of minimally-invasive cryoablation technology, the ProSense System, that destroys tumors by freezing as an alternative to surgical tumor removal, announced that interim data from the ICE3 Clinical Trial on cryoablation of small, low-risk breast cancer was featured by Co-Primary Investigator Kenneth Tomkovich, M.D., at RSNA 2021.
News | Clinical Trials
IceCure Medical's Interim Results of the ICE3 Clinical Trial for Early-Stage Breast Cancer Cryoablation featured at RSNA 2021

December 7, 2021 — IceCure Medical Ltd., developer of minimally-invasive cryoablation technology, the ProSense System ...

Time December 07, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now